Suara.com – Developed countries such as the United States and Britain entered the group Elderly or elderly people as the priority group of recipients vaccine Covid-19. Meanwhile in Indonesia, the vaccine program is only limited to the productive age group of 18 to 59 years.
Chairperson of the Covid-19 Task Force for the Indonesian Doctors Association (IDI), Prof. Dr. Zubairi Djoerban, Sp. PD-KHOM analyzed this was done to reduce transmission more quickly, so that the Covd-19 pandemic could be quickly controlled.
Moreover, he continued, productive age is often an agent of transmission because they have a high level of mobility, such as leaving the house, contracting the virus and then bringing it to a home where there are elderly and other vulnerable groups.
Even though this vulnerable group can experience more severe infections when contracting Covid-19, the risk of death is even higher than those of productive age who have a better immune system.
Also Read:
1.2 Million Sinovac Vaccines Have Been Sent All Over Indonesia, Here Is The List
“I think that what Indonesia is doing is also good. The assumption is that working-age adults are certainly younger, more active and have high mobility. So, this strategy is expected to reduce transmission faster than vaccinating the elderly first,” said Prof. Zubairi via his twitter tweet quoted Suara.com, Tuesday (5/1/2021).
In addition, said Prof. Zubairi’s absence of data on the safe Sinovac vaccine to use for the elderly is thought to be the reason. Given the current Sinovac vaccine that is available in Indonesia and ready to be injected.
Meanwhile, the Sinovac vaccine clinical trial in Bandung was conducted for the 18 to 59 year age category. The Sinovac vaccine that is tested in the elderly is carried out in another country, not Indonesia.
“I think the answer is simple. What? Yes, because we do not have enough data about the efficacy of the Sinovac vaccine in the elderly. The clinical trial in Bandung involves people aged 18 to 59 years. We are still waiting for interim reports from other countries,” he said. he said.
This situation is inversely proportional to the United States and Britain, which first used the vaccine made by American and German pharmaceutical companies, namely the Pfizer BioNTech vaccine which is said to be safe for all ages, including the elderly.
Also Read:
At the Brawijaya Campus, Jokowi talks about 2020 to the Corona vaccine
“Meanwhile, the strategy in England and America is clear. They use Pfizer BioNTech which is effective at all ages. Including for the elderly and children. We’ll see how it will affect each country, with their own strategies,” he concluded.
– .
